Evidence map›Paper›PMID 42016304›Full record

ReviewESMO real world data and digital oncology2026

ONMORE-Africa: diagnosing and building real-world oncology studies in Morocco and Africa.

H A Tafenzi, F Selmouni, H Elmarrachi, N Ismaili, I Essadi, R Belbaraka

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

H A TafenziMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
F SelmouniInternational Agency for Research on Cancer, Auvergne-Rhône-Alpes, Lyon, France.
H ElmarrachiFaculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
N IsmailiFaculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
I EssadiBiosciences and Health Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
R BelbarakaMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•ONMORE-Africa: first standardised assessment of Moroccan oncology infrastructure.•Quantifies work force shortages, consumables, biobanking, and digital gaps.•Defines lean minimum dataset and interoperability standards for pooled RWE.•Staged implementation, pilot testing, quality assurance, and capacity building for regional RWE.•Enables co-design of policy, training, and registry pilots with stakeholders.

Indexed as

LMICsresearch limitationRWE

Identifiers

PMID42016304
PMCPMC13094424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.